Ann Nucl Med
- MIYAMOTO M, Okuyama C, Kagawa S, Kusano K, et al
Correction: Radiation dosimetry and pharmacokinetics of the tau PET tracer
florzolotau (18F) in healthy Japanese subjects.
Ann Nucl Med. 2024 Mar 7. doi: 10.1007/s12149-024-01917.
- OZUTEMIZ C, Koksel Y, Froelich JW, Rubin N, et al
The active papillary muscle sign in 18F-FDG PET/CT cardiac sarcoidosis exams and
its relationship with myocardial suppression.
Ann Nucl Med. 2024 Mar 2. doi: 10.1007/s12149-024-01910.
Appl Radiat Isot
- PENG L, Yang T, Zhang D, Wu R, et al
Optimization and automation of the radiosynthesis of [(18)F]Lu-LuFL as a
clinically useful PET ligand targeting FAP for tumor imaging.
Appl Radiat Isot. 2024;207:111247.
Brain
- DE MEYER S, Blujdea ER, Schaeverbeke J, Reinartz M, et al
Longitudinal associations of serum biomarkers with early cognitive, amyloid and
grey matter changes.
Brain. 2024;147:936-948.
Clin Nucl Med
- SU D, Zhang Y, Li Z, Yang H, et al
177 Lu-DOTATATE in the Treatment of Recurrent Pheochromocytoma With Multiple
Metastases.
Clin Nucl Med. 2024;49:338-339.
- DONG Z, Guo Z, Guan M, Zhang Y, et al
FDG-Avid Periprosthetic Particle Disease Mimicking Osteosarcoma Recurrence.
Clin Nucl Med. 2024;49:356-358.
- TANG P, Cui F, Jiang C, Zhou Y, et al
Comparison of Lugano Criteria Versus RECIL and PERCIST as Prognostic Factors in
Diffuse Large B-Cell Lymphoma.
Clin Nucl Med. 2024;49:308-311.
- KIM K, Ha M, Kim SJ
Comparative Study of Different Imaging Modalities for Diagnosis of Bone
Metastases of Prostate Cancer: A Bayesian Network Meta-analysis.
Clin Nucl Med. 2024;49:312-318.
- KOC ZP, Ozcan PP, Tombak A, Sonmezoglu K, et al
Multiple Nervous System Involvement of Erdheim-Chester Disease With Responsive
Perinephritic Hypermetabolism.
Clin Nucl Med. 2024;49:e166-e167.
- DO D, Suhaj P, Benes J, Matej R, et al
Aneurysmal 99m Tc-HMPAO Uptake in Brain Death.
Clin Nucl Med. 2024;49:348-350.
- GEORGOPOULOU AN, Zerzi C, Samaras V, Rondogianni P, et al
How Early Can Checkpoint Inhibitors Induce a Complete Metabolic Response in
Chemorefractory Hodgkin Lymphoma?
Clin Nucl Med. 2024;49:327-329.
- BABACAN GB, Acar Tayyar MN, Sahin MC, Sengiz Erhan S, et al
Unusual Presence of Synchronous Primary Ovarian and Thyroid Extranodal
Non-Hodgkin Lymphoma Without Lymph Node Involvement.
Clin Nucl Med. 2024 Feb 2. doi: 10.1097/RLU.0000000000005108.
- XU F, Liu F
Intense 18 F-Prostate-Specific Membrane Antigen Uptake and Mild 18 F-FDG Uptake
in a Biopsy-Proven Pulmonary Hemangioma.
Clin Nucl Med. 2024;49:375-376.
- LI H, Song L, Zhao M, Zhang W, et al
Increased Prostate-Specific Membrane Antigen Uptake in a Gallbladder Stone.
Clin Nucl Med. 2024;49:344-345.
- SINGH K, Bennett O, Wegner EA, Marsden A, et al
18F-FDG PET/CT in Pediatric Immunoglobulin G4-Related Disease.
Clin Nucl Med. 2024 Mar 1. doi: 10.1097/RLU.0000000000005151.
- ROSAR F, Ezziddin S, Bittenbring JT, Christofyllakis K, et al
Mast Cell Sarcoma Mimicking Lymphoma or Metastatic Disease on 18F-FDG PET/CT.
Clin Nucl Med. 2024 Mar 8. doi: 10.1097/RLU.0000000000005162.
- MAKI T, Matsusaka Y, Egi R, Seto A, et al
Visualization of the Internal Thoracic Arteries in Giant Cell Arteritis on
18F-FDG Semiconductor PET/CT.
Clin Nucl Med. 2024 Mar 8. doi: 10.1097/RLU.0000000000005158.
J Cereb Blood Flow Metab
- LETERRIER S, Goutal S, Hugon G, Goislard M, et al
Imaging quantitative changes in blood-brain barrier permeability using
[(18)F]2-fluoro-2-deoxy-sorbitol ([(18)F]FDS) PET in relation to glial cell
recruitment in a mouse model of endotoxemia.
J Cereb Blood Flow Metab. 2024 Mar 5:271678X241236755.
J Nucl Cardiol
- PATEL KK, Singh A, Qarajeh R, Shatla I, et al
Prevalence of Balanced Ischemia on PET Relative Perfusion Imaging Among Patients
with High-Risk Coronary Artery Disease.
J Nucl Cardiol. 2024 Mar 2:101836. doi: 10.1016/j.nuclcard.2024.101836.
J Nucl Med
- YEH R, O'Donoghue JA, Jayaprakasam VS, Mauguen A, et al
First-in-Human Evaluation of Site-Specifically Labeled (89)Zr-Pertuzumab in
Patients with HER2-Positive Breast Cancer.
J Nucl Med. 2024 Jan 25:jnumed.123.266392. doi: 10.2967/jnumed.123.266392.
- CUZZANI G, Fortunati E, Zanoni L, Nanni C, et al
Case Report: Pulmonary Actinomyces Infection Mimics Lung Cancer on
[(68)Ga]Ga-FAPI PET/CT.
J Nucl Med. 2024 Mar 7:jnumed.123.267155. doi: 10.2967/jnumed.123.267155.
- FAROLFI A, Armstrong WR, Djaileb L, Gafita A, et al
Differences and Common Ground in (177)Lu-PSMA Radioligand Therapy Practice
Patterns: International Survey of 95 Theranostic Centers.
J Nucl Med. 2024;65:438-445.
- SCHILHAM MGM, Somford DM, Kusters-Vandevelde HVN, Hermsen R, et al
Prostate-Specific Membrane Antigen-Targeted Radioguided Pelvic Lymph Node
Dissection in Newly Diagnosed Prostate Cancer Patients with a Suspicion of
Locoregional Lymph Node Metastases: The DETECT Trial.
J Nucl Med. 2024 Jan 4:jnumed.123.266495. doi: 10.2967/jnumed.123.266495.
- HOVHANNISYAN-BAGHDASARIAN N, Luporsi M, Captier N, Nioche C, et al
Promising Candidate Prognostic Biomarkers in [(18)F]FDG PET Images: Evaluation in
Independent Cohorts of Non-Small Cell Lung Cancer Patients.
J Nucl Med. 2024 Mar 7:jnumed.123.266331. doi: 10.2967/jnumed.123.266331.
- LI C, Chen Q, Tian Y, Chen J, et al
(68)Ga-FAPI-04 PET/CT in Non-Small Cell Lung Cancer: Accurate Evaluation of Lymph
Node Metastasis and Correlation with Fibroblast Activation Protein Expression.
J Nucl Med. 2024 Mar 7:jnumed.123.266806. doi: 10.2967/jnumed.123.266806.
- HARTRAMPF PE, Huttmann T, Seitz AK, Kubler H, et al
Prognostic Performance of RECIP 1.0 Based on [(18)F]PSMA-1007 PET in Prostate
Cancer Patients Treated with [(177)Lu]Lu-PSMA I&T.
J Nucl Med. 2024 Mar 7:jnumed.123.266702. doi: 10.2967/jnumed.123.266702.
- DIERKS A, Gable A, Rinscheid A, Wienand G, et al
First Safety and Efficacy Data with the Radiohybrid (177)Lu-rhPSMA-10.1 for the
Treatment of Metastatic Prostate Cancer.
J Nucl Med. 2023 Dec 21:jnumed.123.266741. doi: 10.2967/jnumed.123.266741.
Nat Rev Neurol
- KIANI L
Regional vulnerability to Abeta and tau pathology.
Nat Rev Neurol. 2024;20:133.
Nucl Med Commun
-
Role of textural analysis parameters derived from FDG PET/CT in differentiating
hepatocellular carcinoma and hepatic metastases: Erratum.
Nucl Med Commun. 2024;45:353.
- GONDHANE A, Verma P, Chandak A, Basu S, et al
Prospective evaluation of 68Ga-NODAGA-RGD PET-CT in patients of carcinoma thyroid
with thyroglobulin elevated negative radioiodine scintigraphy (TENIS) with a
head-to-head comparison with FDG-PET/CT.
Nucl Med Commun. 2024 Mar 6. doi: 10.1097/MNM.0000000000001828.
- AL-NAHHAS A, Jawad ASM
F-18-FDG PET-CT in investigating possible malignancy associated with rheumatic
disease: beware of excessive radiation.
Nucl Med Commun. 2024 Mar 6. doi: 10.1097/MNM.0000000000001834.
- GIBBONS T, Perkins A, Barnett J
Safety, biodistribution and radiation dosimetry of the Arg-Gly-Asp peptide 99m
Tc-maraciclatide in healthy volunteers.
Nucl Med Commun. 2024;45:295-303.
Nuklearmedizin
- LIU Y, Tang W, Huang Z
Correction: 99mTc-MDP Bone Scan and 18F-FDG PET/CT Imaging of Primary Hepatic
Osteosarcoma.
Nuklearmedizin. 2024 Mar 4. doi: 10.1055/a-2275-1035.
PLoS One
- FA-NGOEN C, Kaewmongkol G, Inthong N, Tanganuchitcharnchai A, et al
Serological detection of Rickettsia spp. and evaluation of blood parameters in
pet dogs and cats from Bangkok and neighboring provinces.
PLoS One. 2024;19:e0297373.
Semin Nucl Med
- GUJA KE, Ganjoo KN, Iagaru A
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET.
Semin Nucl Med. 2024 Mar 2:S0001-2998(24)00012.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016